SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

InVivo Therapeutics Holdings Corp (NVIV)

Add NVIV Price Alert      Hide Sticky   Hide Intro
Moderator: TheHound
Search This Board:
Last Post: 10/20/2016 2:44:50 PM - Followers: 197 - Board type: Free - Posts Today: 0

About InVivo Therapeutics 

InVivo Therapeutics Corporation is a Cambridge, MA based medical device company founded to develop and commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI).Currently, there are no treatment options for SCI patients to successfully restore function following a spinal cord injury. Existing treatments consist of a collection of approaches that only focus on symptoms of SCI, such as decompression and mechanical stabilization of the spinal cord, rather than on the underlying pathology. InVivo intends to develop its novel Neuro-Spinal Scaffold to treat acute SCI and Neuro-Scaffold Plus Stem Cells to treat chronic SCI. - See more at:

In the Spotlight

October 23, 2015 InVivo Therapeutics Reports Significant Improvement of First Patient Implanted with Neuro-Spinal Scaffold™

October 19, 2015   InVivo Therapeutics Announces Expansion of Number of Patients in Pilot Study

October 1, 2015 Early Promise for a New Paralysis Treatment

September 9, 2015 InVivo Therapeutics Announces Mount Sinai Hospital in New York City as New Site for Neuro-Spinal Scaffold™ Clinical Trial

September 8, 2015 InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study

August 20, 2015 InVivo Therapeutics Announces Enrollment of Fourth Patient in Pilot Spinal Cord Injury Trial

August 13, 2015 InVivo Therapeutics’ CEO and Chairman, Mark Perrin, Interviewed by Maria Bartiromo on FOX Business Network’s “Mornings with Maria”

July 6, 2015 InVivo Therapeutics Reports Significant Improvement of Second and Third Patients Implanted with Neuro-Spinal Scaffold

June 22, 2015 InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells

June 5, 2015- InVivo Therapeutics Announces Enrollment of Third Patient in Pilot Spinal Cord Injury Trial

April 16, 2015InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) to Ring The Nasdaq Stock Market Opening Bell

April 8, 2015 - InVivo Therapeutics Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ

March 26, 2015 - InVivo Therapeutics Announces Reopening of Enrollment for Subjects Three through Five for Anticipated Completion of Ongoing Pilot Trial

March 11, 2015 - InVivo Therapeutics Reports 2014 Year End Financial Results and Business Update

February 23, 2015 - InVivo Therapeutics Announces Froedtert & the Medical College of Wisconsin as New Clinical Trial Site for Neuro-Spinal Scaffold

February 9, 2015 - InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer

February 5, 2015 - InVivo Therapeutics Announces CEO Mark Perrin Named Chairman of the Board

February 2, 2015 - Video - Second Implantation of InVivo Therapeutics Neuro-Spinal Scaffold In Charlotte

January 22, 2015 - InVivo Therapeutics Announces Enrollment of Second Subject in Pilot Spinal Cord Injury Trial

January 21, 2015 - Zacks Small Cap Research Report- $3.25 Price Target

January 21, 2015 - Jordan's 1st Patient Video

January 21, 2015 - InVivo Therapeutics Reports Three-Month Update of First Acute Spinal Cord Injury Subject Implanted with Neuro-Spinal Scaffold

December 18, 2014 - Microcap - NVIV Research Report **A MUST READ**

December 16, 2014 - InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial

November 11, 2014 - Scottsdale man hopes to walk again after groundbreaking surgery

October 29, 2014 - InVivo Therapeutics Receives FDA Approval to Broaden Inclusion Criteria and Add 14 Additional Sites (20 Total) for Ongoing Pilot Trial

October 15, 2014 - InVivo Therapeutics Announces First Subject Enrolled in Pilot Spinal Cord Injury Trial

April 28, 2014 - InVivo Therapeutics Initiates First Clinical Trial of Neuro-Spinal Scaffold


Ongoing Human Trials:
SEC Filings:
Recent News:
Share Structure:
Investor Presentation:



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NVIV News: InVivo Therapeutics Announces Beth Israel Deaconess Medical Center as New Site for INSPIRE Study 10/20/2016 08:00:00 AM
NVIV News: InVivo Therapeutics Announces Foothills Medical Centre in Calgary, Alberta as New Canadian Site for INSPIRE Study 10/19/2016 08:00:00 AM
NVIV News: Current Report Filing (8-k) 10/11/2016 08:05:07 AM
NVIV News: Current Report Filing (8-k) 10/04/2016 08:01:17 AM
NVIV News: Current Report Filing (8-k) 09/27/2016 08:05:49 AM
#5292  Sticky Note A Year in Review: 2015 FactMan777 01/03/16 12:24:23 AM
#5602   was dead right. that dip was perfect add spot. dshade 10/20/16 02:44:50 PM
#5600   U first. TheHound 10/19/16 11:34:55 AM
#5599   Great news for you. News is out. Johnny Penstock 10/19/16 09:20:46 AM
#5597   On October 16, 2016, the CEO stated the DDobserver 10/19/16 08:53:22 AM
#5596   The FDA hold is lifted that's very good news Giovinco 10/19/16 08:41:51 AM
#5595   I am relaxed. I only asked you a DDobserver 10/17/16 02:58:25 PM
#5594   you need to relax man, I am not Giovinco 10/17/16 02:25:57 PM
#5593   So what does the TICK SIZE PILOT PROGRAM DDobserver 10/17/16 02:18:30 PM
#5592   New 5 cents spread started today for NVIV, Giovinco 10/17/16 10:16:43 AM
#5591   Inspire trial BioBull1 10/14/16 09:42:46 AM
#5590   I do not think NVIV is a buy DDobserver 10/14/16 09:34:36 AM
#5589   If, and I mean If, this stock sees BioBull1 10/14/16 08:23:31 AM
#5588   NVIV Clear Buyout Target, Primary Endpoint Already Met, Giovinco 10/14/16 07:50:16 AM
#5587   Based upon your model what year will it DDobserver 10/13/16 11:33:20 PM
#5586   $20share-600Mcap cap is minimum that's only 3x the Giovinco 10/13/16 03:23:10 PM
#5585   You see this trading with a valuation of BioBull1 10/13/16 03:17:43 PM
#5584   don't be ridiculous, $4.3 a share is only Giovinco 10/13/16 03:06:10 PM
#5583   Even at 4 bucks a share, the market BioBull1 10/13/16 02:56:22 PM
#5582   Investors may once again face additional dilution unless BioBull1 10/13/16 02:50:15 PM
#5581   one can't go wrong buying shares anywhere near TheHound 10/13/16 02:48:39 PM
#5580   DD, I agree with everything you've stated. I BioBull1 10/13/16 02:45:08 PM
#5579   So what ? I am paying only $4.35 Giovinco 10/13/16 02:22:32 PM
#5578   nope, was not. I appreciate your points. dshade 10/13/16 02:15:50 PM
#5577   the value of the company isn't defined by TheHound 10/13/16 01:42:09 PM
#5576   If you are referring to me you are DDobserver 10/13/16 12:56:41 PM
#5575   Old CEO trying to influence after he sold dshade 10/13/16 12:37:04 PM
#5574   You and I must not be looking at DDobserver 10/13/16 12:20:49 PM
#5573   Excellent buying opportunity now at $4.35 Giovinco 10/13/16 10:20:47 AM
#5572   Thank you for supporting Jordan's Journey. On Monday, twins11 10/12/16 08:36:43 PM
#5571   Tomorrow is jordens 2 year mark !! In twins11 10/12/16 08:35:19 PM
#5570   Apparently there were two enrollment holds. FactMan777 10/12/16 03:54:05 PM
#5569   i think the cryptic message reads more like TheHound 10/08/16 04:22:19 PM
#5568   Gents....if I understand your cryptic message it reads DDobserver 10/08/16 03:57:25 PM
#5567   Nice work Hound. Citrati 10/07/16 08:43:29 PM
#5566   Thanks for sharing your perspective - your posts Tadedge 10/07/16 10:03:20 AM
#5565   Unless you are referring to pause following the Riddakilla 10/06/16 08:56:23 PM
#5564   Hello Factman, Riddakilla 10/06/16 08:42:02 PM
#5563   Fair points. Thanks for sharing. Perkin78 10/06/16 07:59:52 PM
#5562   FactMan777 Update FactMan777 10/06/16 03:25:52 PM
#5561   9-30-16 FDA disapproved proposed Cervical Study. TheHound 10/06/16 02:33:54 PM
#5559   haven't been watching? swing trading this is like TheHound 09/30/16 08:19:30 AM
#5558   I'm not sure you've been watching, then. Johnny Penstock 09/29/16 11:22:27 PM
#5557   that's clearly not the case. TheHound 09/29/16 11:13:35 PM
#5556   Unfortunately, every time there is news, the pps Johnny Penstock 09/29/16 10:42:16 AM
#5555   I'm ready for some news to ride the TheHound 09/28/16 12:07:11 AM
#5554   Usually the "facts" are what matter in the cybermich 09/16/16 09:59:08 AM
#5553   how is fact working for you kund 09/14/16 12:46:15 AM
#5552   New Seeking Alpha Article... FactMan777 08/22/16 10:24:14 PM
#5550   More and more data shows efficacy. nice. dshade 08/18/16 11:11:37 AM
#5549   InVivo Therapeutics Announces Northwestern Medicine as New Site MDizzle 08/18/16 08:07:51 AM